When you receive a U.S. patent office action, don’t rush to amend the claims; first determine whether it is Non-Final or Final before responding, because the response deadlines differ significantly depending on the type.

Upon receiving a U.S. patent Office Action (OA), the first step is not to amend the claims, but to determine whether it is Non-Final or Final. The response deadline for a Non-Final is usually 3 months, extendable to 6 months; the response deadline for a Final is likewise 3 months, but extension fees are higher, and the response paths are entirely different—either amend and argue under 37 C.F.R. §1.116, or file a Request for Continued Examination (RCE) to reopen prosecution, or appeal to the Patent Trial and Appeal Board (PTAB). If you get the type wrong, you may merely incur additional costs, or you may end up abandoning the application outright.

Why is the response logic different between Non-Final and Final?

A Non-Final OA is the first or second substantive Office Action issued by the examiner; at this point, the examiner is still at the stage of listening to you. You may amend the claims, cancel claims, add dependent claims, and you may also submit an affidavit or comparative experimental data. The examiner will reconsider all issues. A Final OA means that the examiner believes the case has already been examined; unless your amendment can overcome all grounds of rejection and does not introduce new issues, the examiner will not proceed to the next substantive examination. In practice, many clients encountering a Final for the first time think they can still amend as they did last time, only to find that the examiner directly issues an Advisory Action saying that the amendment does not count.

The response period is only 3 months; it can be extended, but it will cost money.

Whether Non-Final or Final, the statutory response deadline set by the U.S. Patent and Trademark Office (USPTO) is 3 months from the OA mailing date, extendable to 6 months. Extension fees are charged in tiers under 37 C.F.R. §1.17: the 1-month extension fee is about $40 for a small entity, about $160 for 2 months, and about $360 for 3 months. The extension fee for a Final OA is slightly higher, and if no response is filed within 6 months, the application will be deemed abandoned. We generally advise clients to finalize the claim amendment plan within 2 weeks after receiving the OA, leaving time for translation, proofreading, and filing. Cross-border e-commerce sellers handling multiple U.S. applications at the same time should mark the 3-month deadline for each on their calendars.

Three paths after Final: amendment, RCE, appeal.

After a Final Office Action, there are three standard options. First, file a response under 37 C.F.R. §1.116, but the examiner will accept only amendments that overcome all grounds of rejection; otherwise, the examiner will issue an Advisory Action and maintain final status. Second, file an RCE (Request for Continued Examination). The fee is approximately $1,360 for a large entity, half for a small entity, and half again for a micro entity. After an RCE is filed, the examiner will issue a new Non-Final Office Action, which effectively gives you another opportunity to respond. Third, file a Notice of Appeal with the PTAB; the fee is approximately $840 for a large entity, and an appeal brief must be filed within 2 months. In practice, if there are only minor amendments to the scope of the claims, pursuing an RCE is more cost-effective; if the examiner's obviousness determination on the core claims is clearly erroneous, an appeal is worthwhile.

Where is the boundary for amending claims when responding?

U.S. patent law imposes strict limits on amendments. 35 U.S.C. §132 prohibits the introduction of new matter, meaning an amendment cannot go beyond the disclosure of the original specification and drawings. 37 C.F.R. §1.121 provides that amendments must be marked in the specified format, for example, deleted claims in brackets and added matter underlined. Many clients want to take a paragraph from the specification and insert it into the claims, but if there is no literal support, the examiner will reject it as new matter. We generally recommend preparing a claim chart before responding, clearly listing the specification paragraph numbers corresponding to each amendment, so that the examiner can see at a glance that your amendment has support.

Common types of rejection determine the response strategy.

The most common rejections in U.S. patent Office Actions are obviousness rejections under 35 U.S.C. §103 and novelty rejections under §102. A §103 rejection usually cites two to three references; when responding, one must argue that there is no teaching, suggestion, or motivation (Teaching, Suggestion, Motivation), or that the references cannot be combined. A §112 rejection involves inadequate disclosure in the specification or unclear claims; this type of rejection often requires amending the specification or claims rather than merely arguing. §101 patent eligibility rejections are common in software and business method cases; when responding, one usually cites the USPTO's 2019 Patent Eligibility Guidance (PEG) and the Alice/Mayo two-step test. If you also have a corresponding application in the EU, you may want to pay attention. US and EU trademark and patent filing page. The practical guidelines in it—the review logic on both sides differs considerably.

How should extension fees and RCE fees be calculated so as not to lose out?

USPTO fees are divided into three tiers based on entity type: large entity, small entity (other than micro entity), and micro entity. Small entities receive a 50% reduction, and micro entities receive a 75% reduction. For a first RCE, the fee is $1,360 for a large entity, $680 for a small entity, and $340 for a micro entity. Second and subsequent RCE fees are higher, approximately $2,000 for a large entity. The same applies to extension fees: a 3-month extension is approximately $720 for a large entity and $360 for a small entity. We generally advise clients to first confirm whether they qualify as a small entity or micro entity. Many Chinese outbound companies qualify for small entity status because they have no affiliated companies in the United States, which can save half the fees. If a case has reached Final and an RCE is needed, it is best to amend the claims fully in one go to avoid a second RCE.

Beyond the Response: The Trade-Offs Between Continued Examination, Appeal, and Abandonment

If the examiner still maintains the rejection after Final and you believe the examiner is clearly wrong, you can appeal to the PTAB. The appeal cycle is usually 12–18 months, and the fees include the notice of appeal fee and the appeal brief fee, totaling about $2,000 for a large entity. If you do not want to appeal, you can also file a continuation application, retain the original filing date, and go through examination again. Abandoning the application is the last option, but after abandonment you can file a continuation or continuation-in-part (CIP) to retain some of the content. Cross-border sellers with fast-updating product lines sometimes choose to abandon old applications and refile new applications, but this loses the priority date, so it needs to be weighed. For more overseas application layout ideas, you can refer to the overseas intellectual property topic.

How do we help clients break down a U.S. patent Office Action?

After receiving an Office Action, we first do three things: confirm the type of Office Action and the response deadline; break down each rejection ground and cite the legal basis; and assess the scope for amendment and the strength of arguments. For a Non-Final Office Action, we generally submit a complete response within the 3-month period; for a Final Office Action, we first determine whether an RCE or an appeal is more cost-effective. If the client also has applications in the EU or other countries, we will coordinate the response positions to avoid contradictory statements across jurisdictions. Intellectual property legal services in other countries can cover the coordination of multi-country responses under the PCT and Paris Convention routes.

The foreign-related intellectual property team of Guangdong Zhiming Law Firm has long handled trademark, patent, and copyright matters in the United States and the European Union. If you need support in responding to U.S. patent Office Actions (OAs), please call our hotline at 0755-25986969.

Disclaimer: This article provides general legal information only and does not constitute legal advice on any specific case. Strategies for responding to U.S. patent office actions must be determined based on a comprehensive assessment of the claims, prior art references, and prosecution history. It is advisable to consult an attorney qualified to practice before the U.S. Patent and Trademark Office before taking any action.